Citation Tools

Download PDFPDF

4CPS-031 The primary efficacy endpoint for alirocumab, reductions in low-density lipoprotein cholesterol
Free

Download to a citation manager

Cite this article as:
Polo García J, Preciado Goldaracena J, Larrea Goñi N, et al
4CPS-031 The primary efficacy endpoint for alirocumab, reductions in low-density lipoprotein cholesterol